CARTESIAN THERAPEUTICS INC (RNAC) Stock Income Statement
NASDAQ:RNAC • US8162123025
Current stock price
6.94 USD
-0.1 (-1.42%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.80M | 38.91M | 26.00M | 110.78M | 85.08M | |||
| Operating Expenses | 89.50M | 75.23M | 111.72M | 96.24M | 89.67M | |||
| Research and Development | 58.03M | 45.10M | 71.24M | 72.38M | 68.74M | |||
| Selling, General, and Administrative Expenses | 31.47M | 30.13M | 40.48M | 23.86M | 20.94M | |||
| Operating Income | -86.70M | -36.32M | -85.72M | 14.54M | -4.60M | |||
| Interest Income/Expense | 6.58M | 496.00K | -147.43M | -980.00K | -2.80M | |||
| Other Income/Expense | -2.67M | -33.74M | -4.86M | 21.21M | -2.32M | |||
| Non Recurring Items | -56.70M | -7.58M | -700.00K | 0.00 | 0.00 | |||
| Income Before Taxes | -139.50M | -77.14M | -238.71M | 34.77M | -9.72M | |||
| Income Tax | -9.19M | 287.00K | -19.00M | -609.00K | 15.97M | |||
| Net Income | -130.30M | -77.42M | -219.71M | 35.38M | -25.69M | |||
| EBITDA | -83.75M | -35.17M | -84.87M | 15.82M | -3.35M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -5.02 | -4.48 | -42.50 | 7.28 | -6.74 | |||
| Non GAAP EPS | -5.13 | -11.68 | -10.20 | 8.40 | -9.30 | |||
| Statistics | ||||||||
| Profit Margin | -4658.63% | -198.97% | -844.91% | 31.94% | -30.19% | |||
| Operating Profit Margin | -3099.93% | -93.33% | -329.63% | 13.12% | -5.40% | |||
All data in USD